View recent articles in Biopharma News
BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover »
The biopharma world is here. Endpoints News is an independent news organization, reporting on the »
News on the biopharmaceutical manufacturing industry, focusing on biologics, technology, upstream »
Breaking news from the biotech, clinical research and pharmaceutical industries. BioSpace is The »
Digital publication for experts in drug discovery, pharma, and biotech. Join to influence the »
Novavax’s COVID-19 Vaccine Shows Efficacy in Monkeys, but Does That Translate to Humans? 
SARS-CoV-2 Causes Heart Damage in 20% of People with Mild or No COVID-19 Symptoms 
New Manufacturing Innovator Launches to Change the Way Medicine is Made 
AI-ML Drug Discovery Summit 2021 
Clinical Catch-Up: November 16-20 
Giving the Gift of Time, FDA Approves First Treatment for Rare Childhood Aging Diseases 
Bob Nelsen raises $800M and recruits a star-studded board to build the 'Foxconn' of biotech 
Amgen severs 14-year Cytokinetics partnership, bailing on omecamtiv after mixed PhIII results 
News briefing: AbbVie partner Teneobio expands tech license with CAR-T player Poseida; Argenx buys PRV from Bayer for $98M 
Bristol Myers fronts new Schrödinger alliance with $55M upfront, expanding precision oncology profile 
Tech billionaire Peter Thiel backs a leading psychedelic drug developer 
Merck, expanding coronavirus work, buys a small biotech and its COVID-19 drug 
Amgen cuts Cytokinetics loose after heart drug disappointment 
AstraZeneca, Oxford coronavirus vaccine prevents COVID-19, though study results raise questions 
Merck to acquire Oncolmmune, accelerating development of COVID-19 treatment candidate 
Regeneron’s COVID-19 antibody cocktail receives EUA from FDA 
Canada grants emergency use authorization to Lilly’s COVID-19 antibody, drug maker in strategic manufacturing deal with Samsung 
European Commission approves Sanofi’s MenQuadfi 
COVID-19 vaccine hope for older adults: following release of AstraZeneca, Pfizer, Moderna clinical trial data 
Regeneron COVID-19 drug, used to treat Trump, cleared for emergency use 
Trump administration pushes last-ditch plans to lower drug prices 
SIRIO launches first ‘smart nutra factory’ in Ma’anshan 
CPhI & P-MEC China 2020 adapts to customer needs with hybrid pharma event 
Deep Knowledge Analytics Pharma Division and BiopharmaTrend Form New Joint Venture: Deep Pharma Intelligence 
CDMOs benefit from COVID-19 impacts but mega-cap pharma innovation slowing outsourcing according to CPhI Annual Report